Russell Investments Group, Ltd. Trevena Inc Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$0.2 - $0.5 $24,758 - $61,895	123,791 New	123,791 $51,000
Q1 2018 May 11, 2018	SELL	$1.51 - $2.06 $302 - $412	-200 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$1.4 - $2.6 $18,060 - $33,540	-12,900 Reduced 98.47%	200 $0
Q3 2017 Nov 07, 2017	BUY	$2.22 - $2.79 $29,082 - $36,549	13,100	13,100 $33,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.